End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
16.06
CNY
|
+0.12%
|
|
-2.49%
|
-0.62%
|
Apr. 30 |
Beijing Yuding Additive Manufacturing Research Institute Co., Ltd. announced that it has received funding from CGII Private Fund Co., Ltd, Xi'an CAS Star Technology Incubator Co., Ltd., SDIC Unity Capital Co., Ltd., Lepu Medical Technology Co., Ltd., China Xiong'an Group Fund Management Co., Ltd.
|
CI
| Apr. 19 |
Lepu Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
|
CI
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
58,527
|
48,711
|
40,557
|
42,506
|
30,095
|
29,834
|
-
|
-
|
Enterprise Value (EV)
1 |
61,854
|
51,615
|
41,476
|
41,218
|
30,515
|
26,079
|
25,264
|
24,224
|
P/E ratio
|
33.9
x
|
26.8
x
|
23.8
x
|
18.9
x
|
23.9
x
|
15.1
x
|
13.2
x
|
11.4
x
|
Yield
|
0.6%
|
0.84%
|
1.22%
|
1.48%
|
2.05%
|
2.2%
|
2.3%
|
2.69%
|
Capitalization / Revenue
|
7.51
x
|
6.06
x
|
3.8
x
|
4.01
x
|
3.77
x
|
3.35
x
|
2.94
x
|
2.59
x
|
EV / Revenue
|
7.93
x
|
6.42
x
|
3.89
x
|
3.89
x
|
3.82
x
|
2.93
x
|
2.49
x
|
2.11
x
|
EV / EBITDA
|
27.1
x
|
19.9
x
|
15.9
x
|
13.2
x
|
14.6
x
|
8.75
x
|
7.55
x
|
6.36
x
|
EV / FCF
|
43,129,841
x
|
33,642,681
x
|
19,943,434
x
|
21,830,981
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
0%
|
0%
|
-
|
-
|
-
|
-
|
Price to Book
|
7.88
x
|
4.97
x
|
3.63
x
|
2.89
x
|
1.93
x
|
1.71
x
|
1.55
x
|
1.37
x
|
Nbr of stocks (in thousands)
|
1,769,250
|
1,792,178
|
1,792,178
|
1,850,513
|
1,862,337
|
1,857,638
|
-
|
-
|
Reference price
2 |
33.08
|
27.18
|
22.63
|
22.97
|
16.16
|
16.04
|
16.04
|
16.04
|
Announcement Date
|
2/21/20
|
2/26/21
|
4/25/22
|
4/25/23
|
4/19/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
7,796
|
8,039
|
10,660
|
10,609
|
7,980
|
8,893
|
10,133
|
11,507
|
EBITDA
1 |
2,286
|
2,592
|
2,610
|
3,112
|
2,084
|
2,982
|
3,346
|
3,810
|
EBIT
1 |
1,961
|
2,149
|
2,145
|
2,623
|
1,547
|
2,459
|
2,799
|
3,221
|
Operating Margin
|
25.16%
|
26.74%
|
20.12%
|
24.72%
|
19.39%
|
27.65%
|
27.62%
|
28%
|
Earnings before Tax (EBT)
1 |
2,063
|
2,203
|
2,146
|
2,612
|
1,554
|
2,426
|
2,777
|
3,204
|
Net income
1 |
1,725
|
1,802
|
1,719
|
2,203
|
1,258
|
1,985
|
2,279
|
2,628
|
Net margin
|
22.13%
|
22.42%
|
16.13%
|
20.76%
|
15.77%
|
22.32%
|
22.49%
|
22.84%
|
EPS
2 |
0.9746
|
1.014
|
0.9510
|
1.212
|
0.6757
|
1.063
|
1.219
|
1.409
|
Free Cash Flow
|
1,434
|
1,534
|
2,080
|
1,888
|
-
|
-
|
-
|
-
|
FCF margin
|
18.4%
|
19.09%
|
19.51%
|
17.8%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
62.73%
|
59.18%
|
79.69%
|
60.66%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
83.12%
|
85.14%
|
120.96%
|
85.71%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2000
|
0.2280
|
0.2750
|
0.3410
|
0.3314
|
0.3523
|
0.3692
|
0.4323
|
Announcement Date
|
2/21/20
|
2/26/21
|
4/25/22
|
4/25/23
|
4/19/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
2,025
|
2,784
|
2,428
|
2,848
|
2,437
|
1,864
|
1,958
|
1,721
|
1,922
|
2,279
|
2,518
|
2,208
|
2,080
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-244.2
|
847
|
624
|
467.7
|
699.8
|
413.8
|
417.8
|
15.73
|
609.2
|
643.7
|
697.6
|
601.1
|
590.3
|
-
|
Operating Margin
|
-12.06%
|
30.42%
|
25.7%
|
16.42%
|
28.72%
|
22.2%
|
21.34%
|
0.91%
|
31.7%
|
28.24%
|
27.71%
|
27.23%
|
28.38%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
414.9
|
-
|
-18.39
|
-
|
585.9
|
661.2
|
462.9
|
-
|
-
|
Net income
1 |
-
|
-
|
-
|
-
|
-
|
364.6
|
-
|
-95.4
|
-
|
487
|
549.6
|
404.9
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
19.56%
|
-
|
-5.54%
|
-
|
21.37%
|
21.83%
|
18.34%
|
-
|
-
|
EPS
2 |
-0.1000
|
0.4000
|
0.3100
|
0.2000
|
0.3177
|
0.1900
|
0.2200
|
-0.0500
|
0.2585
|
0.2706
|
0.3024
|
0.2586
|
0.2600
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
0.3410
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.4070
|
-
|
-
|
Announcement Date
|
4/25/22
|
8/26/22
|
10/27/22
|
4/25/23
|
4/25/23
|
8/25/23
|
10/25/23
|
4/19/24
|
4/19/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
3,327
|
2,904
|
919
|
-
|
420
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
1,288
|
-
|
3,755
|
4,569
|
5,610
|
Leverage (Debt/EBITDA)
|
1.455
x
|
1.12
x
|
0.3521
x
|
-
|
0.2015
x
|
-
|
-
|
-
|
Free Cash Flow
|
1,434
|
1,534
|
2,080
|
1,888
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
25%
|
21.1%
|
16%
|
17.6%
|
8.23%
|
11.3%
|
11.6%
|
11.9%
|
ROA (Net income/ Total Assets)
|
11.1%
|
11.1%
|
8.85%
|
9.75%
|
-
|
7.6%
|
7.9%
|
-
|
Assets
1 |
15,520
|
16,246
|
19,428
|
22,591
|
-
|
26,119
|
28,850
|
-
|
Book Value Per Share
2 |
4.200
|
5.470
|
6.240
|
7.940
|
8.380
|
9.380
|
10.40
|
11.70
|
Cash Flow per Share
2 |
1.120
|
1.160
|
1.700
|
1.480
|
0.5300
|
1.420
|
1.450
|
1.660
|
Capex
1 |
556
|
555
|
982
|
903
|
836
|
872
|
897
|
940
|
Capex / Sales
|
7.13%
|
6.91%
|
9.22%
|
8.51%
|
10.48%
|
9.81%
|
8.86%
|
8.17%
|
Announcement Date
|
2/21/20
|
2/26/21
|
4/25/22
|
4/25/23
|
4/19/24
|
-
|
-
|
-
|
Last Close Price
16.04
CNY Average target price
20.69
CNY Spread / Average Target +28.99% Consensus |